Monday, September 14, 2026

New Breakthrough: HER2 Positive Stomach Cancer Treatment with Dual Targeted Therapy Shows 81% Tumor Size Reduction

A study reveals that combining trastuzumab deruxtecan and pertuzumab significantly reduces tumor size in HER2-positive gastric cancer.

2023 Cancer Statistics: Prostate Cancer Surges to Top Spot Among Men in Korea

Prostate cancer is now the most common cancer in South Korean men, reflecting demographic shifts and improved survival rates.

Merz named among ‘Global Sustainable Brands & Leaders 100’ for second consecutive year

Merz Aesthetics Asia recognized for sustainability efforts, CEO Yoo Soo-yeon named Global Sustainable Innovation Leader for second year.

Eun Jae Ahn

No posts to display

Top News

- Our Sponsors Ad -

Follow us